Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 4 · 57.1%Low 1 · 14.3%Moderate 2 · 28.6%High 0 · 0%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Direct match · question page
- Extended vs standard lymph node resection · Lymph nodes retrieved
  Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma 2021 · Cochrane Headline outcomes only
  no estimate extracted
  5 studies · 670 participants
  Moderate
Direct match · question page
- Extended vs standard lymph node resection · Overall survival (3‐year
  Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma 2021 · Cochrane Headline outcomes only
  HR 0.12
  7 studies · 823 participants
  Very low
Direct match · question page
- Extended vs standard lymph node resection · Overall survival (1‐year
  Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma 2021 · Cochrane Headline outcomes only
  HR 0.12
  7 studies · 823 participants
  Very low
Related · question page
- Extended vs standard lymph node resection · Positive resection margins (R1 + R2)
  Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma 2021 · Cochrane Headline outcomes only
  RR 0.81 [0.58, 1.13]
  6 studies · 783 participants
  Very low
Related · question page
- Extended vs standard lymph node resection · Blood loss
  Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma 2021 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 463 participants
  Very low

Extended vs standard lymph node resection

Positive resection margins · people with pancreatic and periampullary adenocarcinoma

It is very uncertain whether extended changes positive resection margins (R1 + R2) compared with standard lymph node resection (very low certainty).

1 finding from 1 review

Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma 2021 · Cochrane Headline outcomes only
RR 0.81 [0.58, 1.13]
6 studies · 783 participants
Very low

Extended vs standard lymph node resection

Overall survival (1‐year · people with pancreatic and periampullary adenocarcinoma

It is very uncertain whether extended changes overall survival (1‐year compared with standard lymph node resection (very low certainty).

1 finding from 1 review

Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma 2021 · Cochrane Headline outcomes only
HR 0.12
7 studies · 823 participants
Very low

Extended vs standard lymph node resection

Overall survival (3‐year · people with pancreatic and periampullary adenocarcinoma

It is very uncertain whether extended changes overall survival (3‐year compared with standard lymph node resection (very low certainty).

1 finding from 1 review

Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma 2021 · Cochrane Headline outcomes only
HR 0.12
7 studies · 823 participants
Very low

Extended vs standard lymph node resection

Postoperative mortality (duration of · people with pancreatic and periampullary adenocarcinoma

Extended showed no clear difference in postoperative mortality (duration of compared with standard lymph node resection (low certainty).

1 finding from 1 review

Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma 2021 · Cochrane Headline outcomes only
Peto OR 1.2 [0.51, 2.8]
7 studies · 843 participants
Low

Extended vs standard lymph node resection

Operating time · people with pancreatic and periampullary adenocarcinoma

1 finding from 1 review

Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma 2021 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 670 participants
Moderate

Extended vs standard lymph node resection

Blood loss · people with pancreatic and periampullary adenocarcinoma

1 finding from 1 review

Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma 2021 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 463 participants
Very low

Extended vs standard lymph node resection

Lymph nodes retrieved · people with pancreatic and periampullary adenocarcinoma

1 finding from 1 review

Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma 2021 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 670 participants
Moderate